Prosfin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prosfin

What is Prosfin? Overview and Quick Facts

Prosfin is a specialized prescription-only medication defined by its core chemical structure and its targeted mechanism as a Testosteron-5α-reductase inhibitor. The drug is formulated for oral administration and is clinically recognized for its role in conditions driven by androgen sensitivity.

Property Description
Active ingredient Finasteride (INN)
Form Film-coated tablets
Pharmacological class 5α-reductase inhibitor (ATC code G04CB01)
Common Use Management of androgen-dependent conditions in adult men
Origin Synthetic 4-azasteroid compound

The Core Identity: What Type of Medicine is Prosfin?

Prosfin is a single-ingredient, prescription-only medication whose activity is derived entirely from its active component, Finasteride. This drug is classified as a 5α-reductase inhibitor, representing a highly specialized class of hormonal modulators. The medicine is supplied as film-coated tablets for systemic delivery via the oral route, confirming its action is internal. Prosfin is a brand produced by Beximco Pharmaceuticals Ltd., which provides this established Finasteride formulation for use in adult male patients.

Composition and Origin: Is Finasteride a Natural or Synthetic Compound?

The active ingredient, Finasteride (chemical formula C23H36N2O2), is a complex synthetic 4-azasteroid compound. This synthetic origin ensures a controlled, precise pharmacological purity. The drug entity's composition consists strictly of the active Finasteride and the required pharmaceutical excipients that form the inert, solid oral delivery matrix. Finasteride works by interfering with the production of a highly active form of testosterone linked to certain physiological changes in men, providing the foundational mechanism for its effect.

General Purpose: What is the Main Objective of Using Prosfin?

The fundamental objective of Prosfin is to modulate potent androgen levels in adult males by suppressing the synthesis of 5α-dihydrotestosterone (DHT). This systemic reduction of DHT concentration provides a primary mechanism to interrupt or slow down physiological processes that are primarily driven by the accumulation or excessive signaling of this potent hormone. Finasteride inhibits the conversion of testosterone to DHT in target tissues, leading to lower serum DHT concentrations, which establishes its therapeutic relevance.

What side effects are possible with Prosfin?

Possible side effects and safety information

The safety profile of Prosfin (Finasteride) is defined by officially documented adverse reactions, which are classified by regulatory authorities based on clinical trial findings and post-marketing surveillance. This information centers primarily on sexual, psychiatric, and reproductive system changes.

Frequency Classification of Adverse Reactions

Side effects are grouped by their reported frequency in official prescribing documents:

  • Common (ge 1/100 to < 1/10): Includes decreased libido, erectile dysfunction, and disorders related to ejaculation.
  • Uncommon (ge 1/1,000 to < 1/100): Covers breast tenderness, breast enlargement (gynecomastia), and rash.
  • Not Known (Frequency cannot be estimated): Reports include depression, suicidal ideation, testicular pain, male infertility, and hypersensitivity reactions such as pruritus or angioedema.

These effects are generally classified under Reproductive system and breast disorders and Psychiatric disorders in regulatory texts.

Serious and Exposure-Related Safety Concerns

The official labeling notes several clinically important safety findings. Serious adverse reactions reported include male breast cancer and an observed increased risk of high-grade prostate cancer in clinical studies using a higher dose of the drug. Furthermore, regulatory documents specify that while sexual adverse reactions may occur early in the course of therapy, these symptoms have been reported to persist after discontinuation of treatment in some individuals.

Population-Specific Safety Constraints

The medicine is not indicated for use in women. It is strictly contraindicated in women who are or may become pregnant due to the risk of abnormal external genital development in a male fetus. Pregnant women must not handle crushed or broken Prosfin tablets due to the potential for the active ingredient to be absorbed. The drug also causes a reduction in Prostate Specific Antigen (PSA) levels, a factor that must be considered when interpreting diagnostic test results.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Prosfin (Finasteride) indicates that acute over-ingestion is generally not associated with specific, severe toxic manifestations. The regulatory body documentation states that even single doses up to 400 mg and multiple doses of 80 mg/day for three months were well tolerated by patients in clinical studies, without resulting in dose-related adverse effects. This high margin of tolerability structures the official approach to overdose management.

Aspect Official Regulatory Statement
Documented Symptoms No specific adverse symptoms or clinical signs are formally documented following acute overdose in regulatory labeling.
Specific Antidote No specific treatment or antidote is known or recommended for Prosfin overdose.
Management Treatment of an overdose is restricted to providing symptomatic and supportive care only.

When to seek immediate medical help:

Despite the absence of documented severe acute toxicity, medical attention must be sought immediately following any suspected ingestion of a dose that exceeds the prescribed amount. This is required even in the absence of observable symptoms, consistent with regulatory guidelines for managing any drug overdose. The overall regulatory assessment establishes that the management approach is solely focused on general supportive measures and observation.

Therapeutic Uses of Prosfin

What Prosfin Treats: Main Uses and Benefits

Prosfin is commonly used across therapeutic domains in adult men where certain symptoms are related to systemic imbalance. This includes conditions presenting with systemic or localized discomfort in two primary domains.

This therapeutic use is primarily relevant for easing symptoms linked to organ-specific functional stress caused by the non-cancerous enlargement of the prostate gland, known as Benign Prostatic Hyperplasia (BPH). The medication is applied to address a cluster of symptomatic manifestations in two major conditions: symptomatic BPH and androgenetic alopecia.

Furthermore, the medication assists in the stabilization of hair thinning and generally supports the promotion of new, visible hair growth in men experiencing hereditary hair loss.

“This use contributes to easing the overall symptom load and may assist with maintaining functional stability.”


Quick Fact: Relief for Lower Urinary Tract Symptoms (LUTS)

The use of Prosfin may assist with reducing the long-term likelihood of acute urinary retention and the subsequent need for BPH-related surgery.

This use is relevant for managing symptoms that interfere with daily functioning and appearance, providing support that helps patients cope more steadily with chronic symptomatic fluctuations.

Regulatory References

  1. DailyMed prescribing information from the NIH

Eligibility and Restrictions for Use

Eligibility for Prosfin Use

Prosfin is strictly indicated for use only in adult men. The eligibility profile is rigorously defined by regulatory authorities based on gender, age, and specific health status.

Absolute Prohibitions

The medication is absolutely contraindicated in women, particularly those who are or may become pregnant. This prohibition is necessary due to the established risk of causing abnormalities of the external genitalia in a male fetus. For this reason, pregnant women must also not handle crushed or broken tablets. Use is also contraindicated in any patient with a known hypersensitivity to finasteride or the medication's excipients.

Age and Organ-Function Restrictions

Safety and effectiveness have not been established in pediatric patients under 18 years of age, and the medicine is therefore not indicated for this population. No specific dosage adjustment is required for use in older adult men.

For patients with chronic renal impairment, no dosage adjustment is considered necessary. However, caution is advised for individuals with liver function abnormalities, as the official regulatory label notes that the effect of hepatic impairment has not been formally studied.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official interaction profile for Prosfin (Finasteride) is characterized by a notable lack of clinically important findings with most commonly tested medicinal products. Government regulatory authorities have concluded that no drug interactions of clinical importance have been identified with the agents formally tested in clinical studies.


Documented Testing and Metabolic Profile

Finasteride was specifically tested for co-administration with a range of widely used substances to assess interaction risks, including Digoxin, Warfarin, Propranolol, Theophylline, Acetylsalicylic acid, and Glibenclamide. No clinically meaningful interactions were observed with these agents.

While the drug is primarily metabolized in the liver via the Cytochrome P450 3A4 (CYP3A4) enzyme, regulatory information states that Finasteride does not appear to affect the overall CYP-linked drug metabolizing system.


Restrictions and Population Notes

  • Contraindicated Combinations: No medicinal products are formally listed as contraindicated for co-administration with Prosfin based on interaction risk in the official regulatory labels.
  • Administration Requirements: The drug may be administered with or without meals, as food does not impact its action. The label contains no requirements for timing separation from other medicines, alcohol, or herbal products.
  • Specific Populations: Caution is noted for patients with liver function abnormalities due to the drug's metabolism in the liver, as this could theoretically impact clearance. However, no dosage adjustments are required for patients with renal impairment.

Mechanism of Action

Selective Enzyme Inhibition of 5alpha-Reductase

Prosfin's mechanism centers on its specific role as a competitive inhibitor of the enzyme Steroid 5alpha-reductase Type II ( 5alpha-R2). This targeted molecular interaction blocks the primary metabolic step that converts the less potent androgen, Testosterone, into the highly active androgen, Dihydrotestosterone (DHT).

Modulating the Androgenic Drive on Tissues

The inhibition of the 5alpha-R2 enzyme results in a profound reduction in the concentration of DHT in the bloodstream and in local, androgen-sensitive tissues. This systemic reduction of the potent hormonal signal diminishes the level of cellular stimulation, allowing for a slow modulation of cellular processes previously driven by heightened androgen signaling.

Temporal Constraints of the Mechanism

While the enzyme inhibition itself occurs rapidly, the resulting physiological changes require months to manifest because they rely on the slow turnover and regression of established tissue structures. Furthermore, the mechanism is continuously reliant on the drug's presence to maintain the suppressed DHT levels; upon cessation of therapy, DHT concentrations fully recover, leading to a reversal of the physiological effects.

Dosage and Administration Information

Instruction Map: How to use Prosfin — Administration Guidelines

Prosfin (Finasteride) is used according to a standardized, continuous daily regimen that varies only in dosage strength based on the specific approved use.


Administration Scope

Instruction Detail
Route of administration Oral administration only, via film-coated tablet.
Dosing schedule For Benign Prostatic Hyperplasia (BPH): 5 mg tablet once daily. For Androgenetic Alopecia: 1 mg tablet once daily.
Timing in relation to meals May be administered with or without meals.
Preparation requirements No preparation is required; the tablet must be swallowed whole.
Age-group administration rules Older Adults: No dosage adjustment is necessary. Pediatric: Not indicated for use in children or adolescents.
Missed-dose rules The instruction is to skip the missed dose and resume the regular schedule with the next dose; do not double doses.
Special procedural conditions Renal Impairment: No dosage adjustment is required for patients with renal insufficiency.

Instruction Classifications (high-level)

Classification Detail
Administration method type Oral
Frequency pattern Daily (once daily)
Prescribing basis Standardized prescribing guidelines.
Use-context constraints Requires indication-specific dosing strength (1 mg vs 5 mg) and long-term continuous use.

Resulting Procedural Structure

Step sequence:

  • The dose taken (1 mg or 5 mg) is determined by the specific approved use.
  • The oral tablet is administered once daily, consistently around the same time.
  • The film-coated tablet must be swallowed whole and is not to be broken or crushed.
  • Treatment must be continued for a sustained, long-term duration, as benefits may take three to six months to be observed.
  • If a dose is missed, the patient should proceed with the next scheduled dose without taking an extra tablet.

Connection to the overall use protocol

The instructions establish a fixed oral, once-daily protocol defined by two distinct, indication-specific dosage strengths. This protocol reinforces that the regimen is a highly consistent, continuous pattern that is maintained long-term and does not require dose adjustment for common patient populations such as older adults or those with kidney impairment.

Recent Clinical Evidence

Prosfin: Recent Clinical Evidence

This section outlines the research that has investigated the drug's effects on pain associated with the condition.

Clinical Efficacy Studies

Clinical trials have been conducted to evaluate the drug's effect. Research reported an outcome compared to placebo in reducing symptom severity. Studies investigated the onset of reported changes, and long-term research has explored continued use.

The primary endpoints in most trials included measures of pain intensity and patient-reported functional scores. Results from Phase III trials reported an outcome in these endpoints compared to the control group.

Combination Therapy Evaluations

Specific research has evaluated whether the drug, when combined with standard physical therapy, is associated with changes in patient mobility. These combination studies evaluated the drug's use over a short time frame.

Further research is needed to fully assess the long-term impact and contribution of each component of the combination regimen.

Dose-Response Research

Studies have evaluated the impact of varying dose levels in participants with severe baseline symptoms. Research examined whether different dosing regimens are associated with changes in the incidence of adverse events and the magnitude of reported change in symptom severity.

Data from dose-ranging studies are available.

Key Studies & References

  1. FINASTERIDE tablet, film coated - DailyMed (National Library of Medicine)

Frequently Asked Questions (FAQ)

Common questions about Prosfin (FAQ)

Q: What exactly is Prosfin used for?

A: Prosfin has two primary uses confirmed by official documents. It is indicated for treating the symptoms of benign prostatic hyperplasia (BPH), which is the non-cancerous enlargement of the prostate gland. It is also approved for use in men for the treatment of male pattern hair loss.

Q: Is Prosfin a prescription medicine or available over the counter?

A: According to official regulatory classifications, Prosfin is a prescription medicine. This means it requires a prescription from an authorized healthcare provider to be obtained.

Q: Are there different strengths or forms of Prosfin (e.g., liquid vs. tablet)?

A: According to the official product information, Prosfin is formulated only as film-coated tablets for oral administration. It is available in two different strengths: a 1 mg tablet and a 5 mg tablet.

Q: Will taking Prosfin make me feel tired or dizzy?

A: Official regulatory listings indicate that adverse effects such as dizziness and somnolence, which is a state of drowsiness or sleepiness, have been reported by some patients. These are classified as having a common or less common incidence.

Q: Does Prosfin have any warnings related to liver function?

A: Regulatory information notes that caution is advised for patients who have abnormalities in their liver function. This is because the drug is processed extensively by the liver. While caution is noted, the regulatory documents describe that a specific change in dose is not generally required for patients with these issues.

Q: Are there specific health conditions that would prevent someone from using Prosfin?

A: Official regulatory documents state that Prosfin is formally contraindicated in certain situations. This includes any known hypersensitivity or allergy to the medicine's components. Furthermore, it is contraindicated in women who are or may become pregnant due to the risk of abnormal development in a male fetus.

Q: Can Prosfin cause changes in weight (gain or loss)?

A: Official regulatory documents that list and classify adverse reactions do not include weight change as a common or uncommon side effect.

Q: Is it normal to feel a bit of nausea or stomach upset when you first start Prosfin?

A: While nausea and abdominal pain have been mentioned in post-marketing surveillance reports, they are not classified as common or uncommon adverse reactions in the primary regulatory documents.

Q: What happens if a person decides to stop taking Prosfin?

A: According to the official clinical pharmacology information, when treatment is stopped, the beneficial effects of the medicine will gradually begin to reverse. The physiological effects are expected to return to the baseline level within nine to twelve months after the last dose.

Q: Is Prosfin meant to be taken for a long period of time?

A: Regulatory information emphasizes that continued use of Prosfin is recommended to sustain the benefit of the medicine. Due to the way the drug works, the beneficial response is typically assessed after at least six months of continuous treatment.

Q: Does Prosfin have any known interactions with alcoholic beverages?

A: Official product information states that the drug may be taken with or without food. Furthermore, the official label does not contain any specific requirements for separating the timing of the drug's administration from consuming alcohol.

Q: Are there any food or diet restrictions while using Prosfin?

A: According to official administration guidelines, Prosfin may be taken either with or without food, as food does not impact its action. The regulatory documents do not list any specific diet restrictions or requirements while using the medicine.

Q: Is Prosfin considered a narcotic or an addictive medicine?

A: Prosfin is classified as a 5alpha-reductase inhibitor, which targets a specific enzyme in the body. According to regulatory classifications, this medicine is not considered a narcotic or a habit-forming substance.

Q: Where can I find the official regulatory warnings for Prosfin?

A: Official warnings and complete prescribing details for Prosfin are compiled in authoritative documents maintained by government health agencies. Examples of these documents include the FDA Professional Label in the United States and the European Summary of Product Characteristics (SmPC) in Europe.

Q: What are the signs of a serious allergic reaction to Prosfin?

A: Regulatory reports note that serious hypersensitivity reactions have occurred in some individuals. Signs of these reactions may include pruritus (severe itching), urticaria (hives), and angioedema (swelling of the lips, tongue, throat, or face).

Q: Does Prosfin affect mood, anxiety, or mental clarity?

A: Regulatory documents specify that mood alterations have been reported in patients using this medicine. These reports include depressed mood, depression, and, in less frequent instances, suicidal thoughts.

Q: What do the clinical studies say about the general effectiveness of Prosfin?

A: Studies officially reviewed by regulatory agencies have demonstrated the general effectiveness of Prosfin for its approved uses. Evidence indicates that it can improve symptoms related to BPH, address certain acute urinary events, and address hair growth and hair loss in men.

Q: Is it safe to drink coffee or caffeine while taking Prosfin?

A: The official regulatory interaction profile does not include any specific warnings against the consumption of coffee or caffeine. No clinically important drug interactions were identified with the various agents that were tested in clinical studies.

Q: Can women who are pregnant or breastfeeding use Prosfin?

A: Prosfin is contraindicated in women who are pregnant or who may become pregnant due to the risk of abnormal external genital development in a male fetus. Regarding breastfeeding, official documents state that it is not known whether the medicine is excreted in human milk.

Q: How long does Prosfin stay in the body after the last use?

A: Official clinical pharmacology data indicates that the mean terminal half-life of the medicine in adult men is approximately 5 to 6 hours. The half-life may be slightly longer in men who are 70 years of age or older.

Q: Is Prosfin a type of steroid or hormone?

A: Prosfin is chemically classified as a synthetic 4-azasteroid compound. It works as a specific inhibitor of the steroid Type II 5alpha-reductase enzyme, which targets the way certain hormones function in the body.

Q: Are the side effects of Prosfin usually temporary?

A: Official regulatory information indicates that while many adverse effects may resolve, sexual adverse reactions are specifically noted as having been reported to persist after discontinuation of treatment in some individuals.

Q: What are the long-term safety considerations for Prosfin?

A: Official regulatory labeling addresses several long-term safety concerns. This information includes an observed increased risk of high-grade prostate cancer in clinical studies using a higher dose of the drug. Additionally, there have been reports of male breast cancer associated with the use of the medicine.

Q: Can Prosfin be used if someone is taking blood thinners?

A: The official interaction profile shows that Finasteride was specifically tested for co-administration with Warfarin (a common blood thinner). No clinically meaningful interaction was observed during these formal studies.

Q: What kind of research has been done on Prosfin's safety profile?

A: The safety profile of the medicine is established based on two primary sources of evidence. This includes findings gathered during clinical trials and ongoing post-marketing surveillance reports, both of which are summarized in the official regulatory documents.

Q: Why is Prosfin often taken at a specific time of day?

A: Official guidelines state that Prosfin is prescribed to be taken once daily. While the specific time of day does not significantly impact the drug's effect, taking it consistently around the same time each day aligns with standard practice for continuous daily regimens.

Q: Are there any restrictions on driving or operating machinery while taking Prosfin?

A: Official product information does not give formal warnings or place restrictions on driving or operating machinery for all users. However, because side effects such as dizziness have been reported, caution may be necessary depending on a person's individual response to the medicine.

Q: Does Prosfin interact with common over-the-counter pain relievers like ibuprofen?

A: Studies reported in official regulatory documents found no clinically important interactions when Prosfin was taken with several commonly used agents, such as aspirin. However, specific testing with Ibuprofen, a common over-the-counter pain reliever, is not explicitly cited in these regulatory documents.

Q: Does Prosfin affect the effectiveness of birth control pills?

A: Official interaction studies did not identify any clinically important drug interactions with the various agents formally tested. However, the regulatory documents do not specifically list or exclude oral contraceptives (birth control pills) among the agents tested.

Q: Does Prosfin interact with common herbal supplements like St. John's Wort?

A: The official interaction profile states that no clinically important drug interactions were identified with the medicinal agents formally tested. However, the regulatory documents do not specifically list St. John's Wort or other herbal products as having been tested for interaction.

Q: What happens if Prosfin is taken with certain vitamins?

A: The official regulatory interaction profile does not specifically list or exclude vitamins among the substances tested. No clinically important drug interactions were identified with the medicinal agents that were formally tested in studies.

Q: Does Prosfin have any interactions with common cold or flu medications?

A: Studies reported in regulatory texts indicate that no clinically important interactions were found with the specific agents that were tested. However, the broad category of common cold or flu medications is not addressed individually in the official interaction profile.

How should Prosfin be stored and disposed of?

How to Store and Dispose of Prosfin (Finasteride Tablets)

Prosfin (finasteride tablets) must be stored at controlled room temperature, typically between 15 C and 30 C. The medication requires specific protection from both moisture and direct light and must be kept from freezing to maintain product stability. Tablets must remain in their original, tightly closed container and should be kept out of the sight and reach of children as a mandatory safety rule.

There are special handling instructions: women who are or may be pregnant must not handle crushed or broken tablets. For disposal, unused or expired medicine must not be thrown away with household trash or down the toilet. Instead, it must be returned to a pharmacy or an official drug take-back program for proper pharmaceutical waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prosfin found in:

A-Z Index: